Hi,
moomoo ID:NaN
Log Out
ENGLISH
  • ENGLISH
  • 中文繁体
  • 中文简体
donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data

TMBR Timber Pharmaceuticals

0.089
-0.007-7.29%
Trading Session 10/05 10:55 ET
High
0.097
Open
0.096
Turnover
525.84K
Low
0.086
Pre Close
0.096
Volume
5.77M
Market Cap
11.84M
P/E(TTM)
Loss
52wk High
0.840
Shares
132.45M
P/E(Static)
Loss
52wk Low
0.083
Float Cap
11.69M
Bid/Ask %
99.15%
Historical High
12.600
Shs Float
130.75M
Volume Ratio
4.07
Historical Low
0.083
Dividend TTM
--
Div Yield TTM
--
P/B
8.94
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
4.41%
Amplitude
11.04%
Avg Price
0.091
Lot Size
1
Float Cap
11.69M
Bid/Ask %
99.15%
Historical High
12.600
Shs Float
130.75M
Volume Ratio
4.07
Historical Low
0.083
Dividend TTM
--
P/B
8.94
Dividend LFY
--
Turnover Ratio
4.41%
Amplitude
11.04%
Avg Price
0.091
Lot Size
1
Price Forecast

No Data

News

Comment

Company Overview More
Timber Pharmaceuticals, Inc. operates as a biopharmaceutical company focused on the development and commercialization of treatments for orphan dermatologic diseases. Its initial focus is on developing non-systemic treatments for rare dermatologic diseases, including congenital ichthyosis, facial angiofibromas in tuberous sclerosis complex, and other sclerotic skin diseases. The company was founded in 2019 and is headquartered in Basking Ridge, NJ.
CEO: Mr. John Koconis
Market: AMEX
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...